Evidence map›Paper›PMID 39259929›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Combining Response and Toxicity Data to Implement Project Optimus.

Robert G Maki, Thomas E Stinchcombe, Gary K Schwartz, Gini F Fleming, Alexia E Iasonos

Abstract readEditorialComment
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Cancer therapy and cachexia.The Journal of clinical investigation · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Robert G MakiDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.ORCID 0000-0002-9853-2528
Thomas E StinchcombeDuke Cancer Center, Duke University, Durham, NC.ORCID 0000-0002-3595-8011
Gary K SchwartzCase Comprehensive Cancer Center, Cleveland, OH.ORCID 0000-0003-1813-5061
Gini F FlemingUniversity of Chicago Comprehensive Cancer Center, Chicago, IL.ORCID 0000-0003-2845-4023
Alexia E IasonosDepartment of Epidemiology & Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.ORCID 0000-0003-0471-8477

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI JOHN N. NORTON · 1985 to 2026
$174.8M
TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Amar Desai · 1987 to 2026
$142.3M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA014236NCI NIH HHS P30 CA043703
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39259929
PMCPMC12674001

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.